Daisuke Kurotaki

Title: Daisuke Kurotaki: Innovator in Antibody Research

Introduction

Daisuke Kurotaki is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of antibody research, particularly in the development of therapeutic agents targeting integrins. With a total of two patents to his name, Kurotaki's work is paving the way for advancements in cancer treatment and inflammatory diseases.

Latest Patents

Kurotaki's latest patents include the "Antihuman α9 integrin antibody and use of the same" and "Anti-α9 integrin antibody and the use thereof." The first patent focuses on a variety of antibodies that specifically recognize human α9 integrin, including monoclonal, chimeric, humanized, and human antibodies. It also details methods for producing these antibodies and hybridoma cells, as well as therapeutic and diagnostic applications. The second patent provides an anti-mouse α9 integrin antibody and emphasizes its therapeutic effects on cancer growth and metastasis, as well as various inflammatory diseases.

Career Highlights

Kurotaki is currently employed at Gene Techno Science Co., Ltd., where he continues to innovate in the field of biotechnology. His research has the potential to significantly impact the treatment of various diseases, showcasing his dedication to improving healthcare through scientific advancements.

Collaborations

Kurotaki collaborates with notable colleagues, including Masashi Kanayama and Shigeyuki Kon. Their combined expertise enhances the research and development efforts at Gene Techno Science Co., Ltd.

Conclusion

Daisuke Kurotaki's contributions to antibody research are noteworthy and hold promise for future medical advancements. His innovative patents reflect a commitment to addressing critical health challenges through scientific inquiry and collaboration.